| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/23/2004 | WO2004080446A1 Treatment of intestinal conditions with n-2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine |
| 09/23/2004 | WO2004080443A1 Treatment and/or prevention of non-viral epithelial damage |
| 09/23/2004 | WO2004080439A1 Drug composition having active ingredient adhered at high concentration to spherical core |
| 09/23/2004 | WO2004066909A3 Method for identifying novel treatments of inflammatory disease in the gut |
| 09/23/2004 | WO2004064721A3 A pyrazolopyrimidine compound and a process for preparing the same |
| 09/23/2004 | WO2004058353A3 Therapeutic use of selective noradrenaline reuptake inhibitors |
| 09/23/2004 | WO2004052365A3 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
| 09/23/2004 | WO2004049964A3 Drug to be introduced tooth or periodontal tissue and apparatus for introducing drug to tooth or periodontal tissue |
| 09/23/2004 | WO2004019921A3 Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases |
| 09/23/2004 | WO2003082268A3 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 09/23/2004 | WO2003043518A3 Methods and products for oral care |
| 09/23/2004 | WO2003011219A3 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 09/23/2004 | WO2003011209A8 Methods of sensitizing hepatocyte cell cultures to hepatitis infection, beads coated with hbv or hcv polypeptides and methods of using such beads to model viral infection or deliver substances into hepatocytes |
| 09/23/2004 | US20040186320 Antioxidant nitroxides and nitrones as therapeutic agents |
| 09/23/2004 | US20040186299 such as 3-(3,5-dimethoxyphenyl)-2-{4-[4-(2,4-dioxothiazolidin-5-ylmethyl)-phenoxy]-phenyl}-acrylic acid; for lowering blood glucose level, serum insulin, triglyceride and free fatty acid levels in animal models of Type II diabetes; for increasing leptin levels with no liver toxicity |
| 09/23/2004 | US20040186178 Amidino compounds useful as nitric oxide synthase inhibitors |
| 09/23/2004 | US20040186174 Hydroxydiphenyl ether compounds |
| 09/23/2004 | US20040186154 treating or preventing a hypercholesterolemia-related or an inflammation-related condition ; apical sodium co-dependent bile acid transport inhibitor and an amount of a cyclooxygenase-2 (COX-2) selective inhibitor or its prodrug; kits |
| 09/23/2004 | US20040186145 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 09/23/2004 | US20040186134 Inhibitors of Factor Xa are useful as anticoagulants in the treatment of cardiovascular disorders associated with thromboses; e.g., 1,1-dimethylethyl 1-[1-(-2-(-3-[2-(5-Chloro-thiophen-2-yl)-ethenesulfonylamino]-2-oxo-piperidin-1-yl)-acetyl)-pyrrolidin-2- yl-methyl]-pyrrolidin-3-yl}-methyl-carbamate |
| 09/23/2004 | US20040186127 E.g., 7-(5-(2-(cyclohexylmethylamino)ethyl)indol-2-yl), 2-methyl-3H-imidazo(4,5-b)pyridine; antiinflammatory agents; antiproliferative agents; autoimmune diseases; reperfusion injuries; osteoporosis; bone disorders; antimetastasis agents |
| 09/23/2004 | US20040186126 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 09/23/2004 | US20040186104 Novel pyridinone and related heterocyclic derivatives |
| 09/23/2004 | US20040186099 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 09/23/2004 | US20040186096 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis |
| 09/23/2004 | US20040186061 Novel derivatives of 3,3-diphenylpropylamines |
| 09/23/2004 | US20040186045 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/23/2004 | US20040185546 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 09/23/2004 | US20040185122 Selective COX-2 inhibition from edible plant extracts |
| 09/23/2004 | US20040185105 Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
| 09/23/2004 | US20040185048 Modulation of IL-2- and IL-15-mediated T cell responses |
| 09/23/2004 | US20040185032 enhanced development of prebiotic gastrointestinal ecology in patients with co-morbid diseases which exhibit problems secondary to impaired gastrointestinal health |
| 09/23/2004 | CA2518999A1 Crystalline and amorphous solids of pantoprazole and processes for their preparation |
| 09/23/2004 | CA2518780A1 Drug composition having active ingredient adhered at high concentration to spherical core |
| 09/23/2004 | CA2518763A1 Treatment and/or prevention of non-viral epithelial damage |
| 09/23/2004 | CA2518385A1 Treatment of intestinal conditions with n-2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine |
| 09/23/2004 | CA2518194A1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 09/22/2004 | EP1460074A1 Substituted amino alkyl compounds |
| 09/22/2004 | EP1460066A1 Piperazine compounds |
| 09/22/2004 | EP1460062A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use |
| 09/22/2004 | EP1459759A1 Drug mobilizing pluripotent stem cells from tissue into peripheral blood |
| 09/22/2004 | EP1459737A1 Granules containing acid-unstable chemical in large amount |
| 09/22/2004 | EP1458865A2 Human vanilloid receptor protein and polynucleotide sequence encoding same |
| 09/22/2004 | EP1458864A1 Tgf-beta-specific covalently closed antisense molecule |
| 09/22/2004 | EP1458863A1 A system for stable expression of sirnas in mammalian cells |
| 09/22/2004 | EP1458857A1 Hxhv virus, nucleic material, peptide material and uses |
| 09/22/2004 | EP1458758A2 Adiponectin fragments and conjugates |
| 09/22/2004 | EP1458754A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 09/22/2004 | EP1458746A2 Cyclic tetrapeptide compound and use thereof |
| 09/22/2004 | EP1458741A2 Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid |
| 09/22/2004 | EP1458723A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/22/2004 | EP1458722A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 09/22/2004 | EP1458718A1 Quinolinones as prostaglandin receptor ligands |
| 09/22/2004 | EP1458717A1 Aroyl pyridinones |
| 09/22/2004 | EP1458714A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 09/22/2004 | EP1458712A2 Novel compounds |
| 09/22/2004 | EP1458710A1 Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
| 09/22/2004 | EP1458709A1 New process |
| 09/22/2004 | EP1458691A2 Benzodiazepine derivatives, preparation thereof and use thereof |
| 09/22/2004 | EP1458688A1 Quinazolinone derivative |
| 09/22/2004 | EP1458687A2 Pyrimidine compounds |
| 09/22/2004 | EP1458683A1 Heteroaryl-substituted aminocyclohexane derivatives |
| 09/22/2004 | EP1458676A2 Compounds for the treatment of inflammatory disorders |
| 09/22/2004 | EP1458411A2 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 09/22/2004 | EP1458400A1 Liquid bisphosphonate formulations for bone disorders |
| 09/22/2004 | EP1458397A1 Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure |
| 09/22/2004 | EP1458392A2 Acridone inhibitors of impdh enzyme |
| 09/22/2004 | EP1458386A1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| 09/22/2004 | EP1458381A1 Triazoles as oxytocin antagonists |
| 09/22/2004 | EP1458379A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 09/22/2004 | EP1458377A1 5ht4 partial agonist pharmaceutical compositions |
| 09/22/2004 | EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458370A1 Treatment of faecal incontinence and other conditions with 1r,2s-methoxamine |
| 09/22/2004 | EP1458367A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| 09/22/2004 | EP1274709B1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines |
| 09/22/2004 | EP1222187B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 09/22/2004 | EP1192165B1 Substituted heterocycle fused gamma-carbolines |
| 09/22/2004 | EP1189904B1 Substituted heterocycle fused gamma-carbolines |
| 09/22/2004 | EP1146874B1 Vitronectin receptor antagonist |
| 09/22/2004 | EP1144402B1 Substituted oximes and hydrazones as neurokinin antagonists |
| 09/22/2004 | EP1124801B1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/22/2004 | EP1100503B1 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
| 09/22/2004 | EP1064950B1 Remedies for hepatitis |
| 09/22/2004 | EP1054869B1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors |
| 09/22/2004 | EP0830347B1 Novel substituted piperazine derivatives having tachykinin receptor antagonists activity |
| 09/22/2004 | EP0623133B1 Substituted amino alkyl compounds |
| 09/22/2004 | CN1531600A New polynucleotides and polypeptides of IFN 2-21 gene |
| 09/22/2004 | CN1531547A Hepatitis C tripeptide inhibitors |
| 09/22/2004 | CN1531546A Peptide compounds |
| 09/22/2004 | CN1531535A Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 09/22/2004 | CN1531533A Crystalline form of omeprazole |
| 09/22/2004 | CN1531529A 4-(benzylidenje-amino)-3-(methylsulfanyl)-4H-(1,2,4) triazin-5-one derivatives having PDE-IV inhibiting and TNF-antagonistic effect for treatment of cardiac diseases and allergies |
| 09/22/2004 | CN1531527A Carbazole derivatives and their use as neuropeptide Y5 receptor ligands |
| 09/22/2004 | CN1531441A Pharmaceutical compositinos which inhibit vascular proliferation and method of use thereof |
| 09/22/2004 | CN1531437A Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by body |
| 09/22/2004 | CN1531435A Methods for inhibiting angiogenesis |
| 09/22/2004 | CN1531425A Urea derivatives as integrin alpha 4 antagonists |
| 09/22/2004 | CN1530366A Sulphonic acid amide for regulating bast peptide activity and derivative thereof |
| 09/22/2004 | CN1530134A Medicine for treating toothache |